冠状动脉血管生成的临床试验:问题,问题,共识:专家小组总结
M Simons1, R O Bonow, N A Chronos
1Angiogenesis Research Center, BIDMC, Harvard Medical School, Boston, MA, USA. msimons@caregroup.harvard.edu
Circulation
|September 12, 2000
概括
治疗性血管生成通过刺激血管生长为缺血性心脏病提供了新的希望. 专家们召开会议,以解决开发这种有前途的治疗策略的关键挑战.
科学领域:
- 心血管医学 心血管医学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 使用生长因子进行治疗性血管新生是治疗晚期缺血性心脏病的新方法.
- 这一策略旨在在患病的心脏中创造新的血液供应.
- 该领域正在从临床前研究向临床应用过渡.
研究的目的:
- 总结专家对冠心病治疗血管生成方面的挑战的共识.
- 确定该领域临床试验进步的关键问题.
- 促进一种统一的方法来开发心脏病的新疗法.
主要方法:
- 召集了来自血管新生基金会和血管新生研究中心的专家小组.
- 在美国心脏协会第72次会议期间进行了讨论.
- 专注于对关键发展挑战的定义和达成共识.
主要成果:
- 确定了治疗性血管生成中的几个未解决的问题.
- 关键的挑战包括了解血管新生生物学,患者选择和终点评估.
- 其他关键因素是输送策略 (基因与蛋白质),输送途径和副作用概况.
结论:
- 在治疗血管新生发育所面临的主要挑战上达成共识.
- 解决这些问题对于成功的临床翻译至关重要.
- 需要进一步的研究和合作来克服治疗冠心病的这些障碍.
相关概念视频
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


